We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

2 hedge funds and large institutions have $2 invested in Ampio Pharmaceuticals Inc. in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more capital invested

Capital invested by funds: $1 → $2 (+$1)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMW
1
Cypress Capital Management (Wyoming)
Wyoming
$2 – – –

AMPE Hedge Fund Activity: Q4 2025 in Review

2 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2025, worth a combined $2 — up 100% from $1 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AMPE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 2 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2025, down from 3 in Q3 2025.
  • Funds reported $2 of Ampio Pharmaceuticals Inc. stock for Q4 2025, up 100% quarter-over-quarter.
  • 0 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2025 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q4 2025.